Exam 2 PPT Slides - Supply Chain

Kevin Vu
Quiz by Kevin Vu, updated more than 1 year ago
Kevin Vu
Created by Kevin Vu over 5 years ago
32
0

Description

Exam 2 PPT Slides - Supply Chain

Resource summary

Question 1

Question
Drug: “Substances that produce a change in cellular or physiological functioning of humans.”
Answer
  • True
  • False

Question 2

Question
For Drugs... End-point of the supply chain drives demand
Answer
  • True
  • False

Question 3

Question
The five factors influencing prescribing behavior are:
Answer
  • Education
  • Colleagues or other health care providers
  • Control and regulatory mechanisms
  • Demands by consumers and society
  • Promotional activities by drug manufacturers
  • Kickbacks from pharmaceutical companies

Question 4

Question
What are the two main acts used by the FDA to control pharmaceuticals?
Answer
  • Food, Drug, and Cosmetic Act
  • Public Health Service Act
  • HIPPA Act
  • Omnibus Act

Question 5

Question
Non-FDA-approved (“off-label”) indications are uses of a product that were not approved by the FDA, but have shown value after approval based on postmarketing research.
Answer
  • True
  • False

Question 6

Question
Non-FDA-approved indications can be promoted by the manufacturer.
Answer
  • True
  • False

Question 7

Question
The FDA started allowing direct advertising in what year?
Answer
  • 1985
  • 1991
  • 1995
  • 1997

Question 8

Question
Drug prices: Suggested price determined by manufacturer is usually a different price (much lower) that is actually paid out-of-pocket by most consumers based on their insurance plan.
Answer
  • True
  • False

Question 9

Question
This phase in the drug development is tested on non-human subject
Answer
  • Phase 0
  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4

Question 10

Question
Which of the phases allow human trail?
Answer
  • Phase 0
  • Phase 1
  • Phase 2
  • Phase 3

Question 11

Question
Phase 1 trials allow 20-80 people (for safety, dosing range, and side effects). Phase 2 trials allow 100-300 people (for effective and further evaluation of safety). Phase 3 trials allow how many people (to confirm effectiveness, monitor side effects, and compared it to commonly used treatments)?
Answer
  • 500-1000
  • 1000-3000
  • 4000-5000

Question 12

Question
Phase 4 trial - post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
Answer
  • True
  • False
Show full summary Hide full summary

Similar

Exam 1 Medications
tera_alise
pharmacology chapter 8 and 20
Alannah Mendoza
module 5 pharmacology chapter 9
Alannah Mendoza
Module 6 Chapters 12/14
Alannah Mendoza
Neuro anatomy
James Murdoch
Respiratory anatomy
James Murdoch
PUBLIC HEALTH
Zinab Keshk
First Aid
Reuben Caruana
Introduction to pharmacology
Ifeoma Ezepue
PHARMACOLOGY BLOCK 1- basic intro
wallacejr@hotmail.co